Biotech boom ahead in 2024, top Jefferies analyst predicts
-
Michael Yee, Jefferies Senior Biotech Analyst, joins 'Fast Money' to talk a possible boom ahead for the biotech sector.
-
Jeg skriver om Bristol Myers der omtales i morgen. Jeg syntes ikke det er en oplagt case endnu.
Man bruge cashflow til at finansiere en spændende pipeline samtidig med man integrer 3-4 selskaber.
Det er usikkerhed * usikkerhed = svært at lokke investorer ind. -
Buy or bail on biotech: Here's what you need to know
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind